Ira Klein, MD, MBA, FACP

Transformative Employer Trends

Navigating Personalized Medicine: Challenges and Opportunities for Employer Plans

09/19/2023

This installment of the Transformative Employer Trends column further explores ways to address access to gene and cell therapies that are transforming management of benefits by employer plans.

This installment of the...

09/19/2023

Journal of Clinical Pathways

Videos

AI in Health Care: Foundations, Myths, and Practical Applications

02/07/2024

Ira Klein , MD, MBA, FACP;

Ira Klein, MD, MBA, vice president of medical affairs for Tempus Labs, provides insight into the future of AI in health care and how it will help cut down on mundane tasks and increase oncologists’ efficiency.

Ira Klein, MD, MBA, vice...

02/07/2024

Journal of Clinical Pathways

Department

Why We Really Do Value-Based Contracting

06/14/2018

Ira Klein , MD, MBA, FACP;

Much has been written in the past few years on the growth of value-based contracting. Previous analyses have explored factors leading to success, advantages over standard contracting, and legislative and...

Much...

06/14/2018

Journal of Clinical Pathways

Business of Pathways

Blockchain, Data Obstruction, and the Promise of Information Sharing for a Value-Based Health Care World

09/13/2018

Ira Klein , MD, MBA, FACP;

The current system of health care delivery and payment has tremendous inefficiencies that relate to an inability to share data among multiple parties, and from that sharing, glean useful and actionable information...

The...

09/13/2018

Journal of Clinical Pathways

Business of Pathways

Engaging in Nontraditional Partnerships to Improve Population Health

11/18/2018

Silas Martin , MS;

Robert A. Bailey , MD;

Ira Klein , MD, MBA, FACP;

Population health, which encompasses the health outcomes of a specific group of individuals, has become an important concept in modern health care systems. Many public policy initiatives in recent years have included...

...

11/18/2018

Journal of Clinical Pathways

Business of Pathways

Eliminating Low-Value Health Care: Where Pathways Approaches Have Succeeded

03/13/2019

Ira Klein , MD, MBA, FACP;

Low-value health care continues to put stress on the US economy, as 20% to 40% of all health spending is designated as wasteful. To date, there have been few broad and sustained efforts to reign in wasteful spending....

...

03/13/2019

Journal of Clinical Pathways

Business of Pathways

Why Threshold Target Performance-Based Metrics May Not Improve Population Health as Much as Treatment Pathways

04/16/2019

Ira Klein , MD, MBA, FACP;

Cheryl Neslusan , PhD;

Pierre Johansen , MSc;

Christian Asseburg , PhD;

Duncan O'Brien , BEc;

Michael Willis , PhD;

Silas Martin , MS;

Many value-based payment agreements (VBAs) and programs incentivize physicians to provide care based on patients’ achievement of treatment targets, especially threshold-based metrics such as maintaining a...

Many...

04/16/2019

Journal of Clinical Pathways

Business of Pathways

Cell and Gene Therapies: Paying It Forward and Adjusting Payment Systems for the Age of Cures

06/18/2019

Ira Klein , MD, MBA, FACP;

Sean McElligott , MS;

Cell and gene therapies represent the next frontier of pharmaceutical development, holding the promise of delivering potentially curative therapies for diseases that have limited treatment options. However, these...

Cell...

06/18/2019

Journal of Clinical Pathways

Business of Pathways

Broadening the Value Assessment Paradigm: Including the Value of Hope and the Value of Insurance

10/18/2019

Sean McElligott , MS;

Ira Klein , MD, MBA, FACP;

*/ /*-->*/ While social media is all about sharing, very little personal preference data makes its way into health plan contracting around specific interventions and pathway programs today. As a result, the...

...

10/18/2019

Journal of Clinical Pathways

Business of Pathways

Health Care as a Preexisting Financial Condition: Individual Costs and Societal Benefits

12/17/2019

Ira Klein , MD, MBA, FACP;

Sean McElligott , MS;

While societally we are still debating the best way to finance health care, we do all agree that when a therapy is available to alleviate illness and suffering, we should find a way to make it available to patients....

While...

12/17/2019

Journal of Clinical Pathways